top of page

Thomson Medical Group Ltd - Consent Solicitation - Launch

COMMENCEMENT OF CONSENT SOLICITATION EXERCISE BY THOMSON MEDICAL GROUP LIMITED (THE "ISSUER") IN CONNECTION WITH ITS S$175,000,000 4.05 PER CENT. NOTES DUE 2025 (ISIN: SGXF89249654) COMPRISED IN SERIES 002 (THE "SERIES 002 NOTES") ISSUED BY THE ISSUER PURSUANT TO THE S$500,000,000 MULTICURRENCY DEBT ISSUANCE PROGRAMME OF THE ISSUER (THE "PROGRAMME").


28 MARCH 2023


Full announcement including disclaimers and offer restrictions available via sgx


"The Issuer wishes to announce that it has today commenced a consent solicitation process to seek the approval of the holders of the Series 002 Notes (the "Noteholders") by way of an Extraordinary Resolution of the Noteholders to, inter alia, (a) amend the ratio of Consolidated Net Debt to Consolidated Total Equity set out in the financial covenant under Clause 8.2.2 of the Trust Deed and Condition 4(b)(ii) of the Series 002 Notes; and (b) amend the notice provisions under Condition 16 of the Series 002 Notes such that notices to the holders of such Series 002 Notes shall also be valid if published on the website of the SGX-ST at http://www.sgx.com (the changes and amendments contemplated above, the "Amendments") (the "Consent Solicitation"). "

Tags:

7 views0 comments

Comments


bottom of page